Related Articles
Growth and molecular interactions of the anti-EGFR antibody Cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: New prospects in the treatment of triple-negative/basal-like breast cancer
Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors
Assessment of CXC ligand 12-mediated calcium signalling and its regulators in basal-like breast cancer cells
Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers
Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells